These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25894030)

  • 21. Benefit/risk ratio of statins in primary prevention.
    Reidenberg MM
    Clin Pharmacol Ther; 2008 Mar; 83(3):498-500. PubMed ID: 17538549
    [No Abstract]   [Full Text] [Related]  

  • 22. The efficacy and cost-effectiveness of statins in low-risk patients.
    Gupta AK
    CMAJ; 2011 Nov; 183(16):1821-3. PubMed ID: 22025650
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins for millions more?
    Lancet; 2014 Feb; 383(9918):669. PubMed ID: 24560042
    [No Abstract]   [Full Text] [Related]  

  • 25. A Reappraisal of the Safety and Cost-Effectiveness of Statin Therapy in Primary Prevention.
    Bleakley C; Pumb R; Harbinson M; McVeigh GE
    Can J Cardiol; 2015 Dec; 31(12):1411-4. PubMed ID: 26386731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and effectiveness of cardiovascular prevention.
    Boyar A
    Am J Cardiol; 2007 Nov; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815
    [No Abstract]   [Full Text] [Related]  

  • 27. Statins underused for primary prevention in older patients.
    Savill P
    Practitioner; 2012 Sep; 256(1754):5. PubMed ID: 23252128
    [No Abstract]   [Full Text] [Related]  

  • 28. "Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
    Messori A; Santarlasci B; Trippoli S; Vaiani M
    BMJ; 2003 Oct; 327(7418):808-9; discussion 809; author reply 809-10. PubMed ID: 14525889
    [No Abstract]   [Full Text] [Related]  

  • 29. [SBU should investigate what is an evidence-based and cost-effective use of statins].
    Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary prevention with over-the-counter statins: a cautionary tale.
    Davidoff F
    Clin Pharmacol Ther; 2005 Sep; 78(3):218-20. PubMed ID: 16153392
    [No Abstract]   [Full Text] [Related]  

  • 32. Statins for primary prevention of cardiovascular disease.
    Majeed A
    BMJ; 2014 May; 348():g3491. PubMed ID: 24868092
    [No Abstract]   [Full Text] [Related]  

  • 33. Statins. Evidence of effectiveness in older patients.
    Nash DT
    Geriatrics; 2003 May; 58(5):35-6, 39-42. PubMed ID: 12756679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins in women for primary prevention--is there evidence to back up their use??
    Fenton A; Panay N
    Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 36. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
    Brugts JJ; Deckers JW
    Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
    [No Abstract]   [Full Text] [Related]  

  • 37. Bad medicine: statins.
    Spence D
    BMJ; 2013 May; 346():f3566. PubMed ID: 23729321
    [No Abstract]   [Full Text] [Related]  

  • 38. Statins for cardiovascular prevention according to different strategies: a cost analysis.
    Ito MK; Nanchen D; Rodondi N; Paccaud F; Waeber G; Vollenweider P; Marques-Vidal P
    Am J Cardiovasc Drugs; 2011; 11(1):33-44. PubMed ID: 21265581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins--should we adjust the risk:benefit ratio?
    Lancet; 2011 Jan; 377(9763):354. PubMed ID: 21277425
    [No Abstract]   [Full Text] [Related]  

  • 40. Statins and the elderly: recent evidence and current indications.
    Schiattarella GG; Perrino C; Magliulo F; Ilardi F; Serino F; Trimarco V; Izzo R; Amato B; Terranova C; Cardin F; Militello C; Leosco D; Trimarco B; Esposito G
    Aging Clin Exp Res; 2012 Jun; 24(3 Suppl):47-55. PubMed ID: 23160507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.